Hogan leads Stanford past UCLA 27-24 to win Pac-12

STANFORD, Calif. (AP) — Kevin Hogan has taken Stanford to a place Andrew Luck never could.

With the NFL's No. 1 overall draft pick and an elite class of seniors gone, a program that weathered the loss of coach Jim Harbaugh once again faced questions. Stanford coach David Shaw answered every one of them, finding a new clutch quarterback along the way.

Hogan threw for 155 yards and a touchdown and ran for 47 yards and another score, helping eighth-ranked Stanford beat No. 17 UCLA 27-24 in the Pac-12 championship game Friday night. The redshirt freshman won game MVP honors while leading the Cardinal to the Rose Bowl for the first time in more than a decade.

"Character," said Shaw, the Pac-12 coach of the year in his first two seasons. "Even when we don't play well, we still play hard. Our guys played with such heart. We made plays when we needed to make plays."

Hogan's biggest highlight came in the biggest moment of the game.

As a defender barreled into him, Hogan hurled a 26-yard tying touchdown pass to Drew Terrell on third-and-15 early in the fourth quarter. Jordan Williamson kicked his second field goal from 36 yards with 6:49 remaining for the go-ahead score, lifting Stanford to its first conference title since the 1999 season.

Many of the sparse crowd announced at 31,622 rushed the field. Players, wearing their all-black uniforms, danced on the sideline and later carried roses — or stuck them in their mouths — while parading around as confetti flew from a stage erected on the field.

What a way to ring in the post-Luck Era: The Cardinal (11-2) will play the winner of the Big Ten title game between Nebraska and Wisconsin in the Rose Bowl on Jan. 1.

UCLA's Brent Hundley threw for 177 yards and a costly interception that set up a Stanford touchdown. He still almost brought the Bruins (9-4) back, but Ka'imi Fairbairn missed a 52-yard field goal wide left in the closing moments of the disappointing loss.

Hogan completed 16 of 22 passes for a fourth win over a ranked opponent in his fourth straight start since unseating Josh Nunes at quarterback. After the Cardinal rolled past UCLA 35-17 last Saturday at the Rose Bowl, it took all 60 minutes to secure another victory in a rare rematch.

Scattered showers made the grass a bit slick, though the surface never seemed to slow down the Bruins, who ran for 284 yards with Johnathan Franklin (194 yards) leading the way. It was the most yards rushing allowed this season by Stanford, which yielded 198 in an overtime victory at Oregon two weeks earlier.

No matter.

The Cardinal did just enough to win their seventh straight game and advance to their third different BCS bowl in as many seasons. They have won at least 11 games each year, part of a run that began behind Harbaugh and Luck, and now has carried on with Shaw and Hogan.

Stanford had won 10 games only three times before in program history (1992, 1940 and 1926).

"It's been fun," Hogan said.

The Bruins made the final road block more difficult than expected.

UCLA converted a pair of third downs before Franklin burst through the middle for a 51-yard touchdown on the game's opening drive. He carried safety Jordan Richards the final 5 yards into the end zone.

Stanford answered quickly. Hogan ran 14 yards on a read-option keeper to convert a long third down, fullback Ryan Hewitt bulldozed through the line on a fourth-and-1 and Stepfan Taylor took a short pass 33 yards, to inches shy of the goal line. On the next play, Hogan faked a handoff and rolled untouched for the tying touchdown.

Taylor finished with 78 yards rushing to eclipse Darrin Nelson's school record of 4,169. Taylor, an outgoing senior, has 4,212 for his career.

Before the Cardinal offense even found their seats on the sideline, Hundley ran 48 yards and scrambled for a 5-yard TD to put UCLA back in front, 14-7.

With the Bruins about to go ahead two scores, Ed Reynolds intercepted Hundley's pass and returned it 80 yards to set up Taylor's short TD run.

Officials ruled that Reynolds, who has returned three interceptions for touchdowns this season, was tackled by Hundley short of the goal line and a replay challenge by Shaw was inconclusive. Reynolds moved into a tie with Oregon State's Jordan Poyer for the Pac-12 lead with six interceptions.

Williamson kicked a 37-yard field goal as the first half expired to give Stanford a 17-14 lead. Fairbairn answered with a field goal from 31 yards on UCLA's opening drive of the second half.

Franklin capped a 12-play, 80-yard drive with a 20-yard TD run late in the third quarter. That gave the Bruins a 24-17 advantage and put Stanford on the brink of its first home loss this season.

Instead, the Cardinal came back in impressive fashion.

After shaking off the safety, Hogan heaved the long touchdown to Terrell just over the cornerback's head. Terrell caught the pass in the short corner and pointed to the poncho-wearing crowd.

"We knew we had to remain calm and play our style," Hogan said. "We kept to it. We pounded the ball, got field position, got the TD to tie it."

Stanford stuffed UCLA three-and-out and Terrell returned the punt 18 yards to the Bruins 43. That set up Williamson's tiebreaking field goal.

One last UCLA drive nearly sent the game to overtime.

Tight end Joseph Fauria caught a pass over the middle on fourth-and-7 and lateraled the ball to Jordon James to finish a 17-yard completion. That helped set up Fairbairn's field goal with 34 seconds left, and the kick never looked on target.

"There's a lot of tears and a lot of disappointment but I think they should be proud of what we accomplished," first-year UCLA coach Jim Mora said.

Stanford has beaten the Bruins five straight games. UCLA was going for its first conference championship since 1998.

The crowd was the smallest at 50,000-seat Stanford Stadium since the Cardinal drew 30,626 against Sacramento State on Sept. 4, 2010.

"It felt like the whole entire game we controlled our own destiny, controlled this ballgame," Bruins defensive lineman Datone Jones said. "We dominated the line of scrimmage and stopped big runs."

___

Antonio Gonzalez can be reached at: www.twitter.com/agonzalezAP

Read More..

Doctors Who Work for Hospitals Face a New Bottom Line





For decades, doctors in picturesque Boise, Idaho, were part of a tight-knit community, freely referring patients to the specialists or hospitals of their choice and exchanging information about the latest medical treatments.




But that began to change a few years ago, when the city’s largest hospital, St. Luke’s Health System, began rapidly buying physician practices all over town, from general practitioners to cardiologists to orthopedic surgeons.


Today, Boise is a medical battleground.


A little over half of the 1,400 doctors in southwestern Idaho are employed by St. Luke’s or its smaller competitor, St. Alphonsus Regional Medical Center.


Many of the independent doctors complain that both hospitals, but especially St. Luke’s, have too much power over every aspect of the medical pipeline, dictating which tests and procedures to perform, how much to charge and which patients to admit.


In interviews, they said their referrals from doctors now employed by St. Luke’s had dropped sharply, while patients, in many cases, were paying more there for the same level of treatment.


Boise’s experience reflects a growing national trend toward consolidation. Across the country, doctors who sold their practices and signed on as employees have similar criticisms. In lawsuits and interviews, they describe growing pressure to meet the financial goals of their new employers — often by performing unnecessary tests and procedures or by admitting patients who do not need a hospital stay.


In Boise, just a few weeks ago, even the hospitals were at war. St. Alphonsus went to court seeking an injunction to stop St. Luke’s from buying another physician practice group, arguing that the hospital’s dominance in the market was enabling it to drive up prices and to demand exclusive or preferential agreements with insurers. The price of a colonoscopy has quadrupled in some instances, and in other cases St. Luke’s charges nearly three times as much for laboratory work as nearby facilities, according to the St. Alphonsus complaint.


Federal and state officials have also joined the fray. In one of a handful of similar cases, the Federal Trade Commission and the Idaho attorney general are investigating whether St. Luke’s has become too powerful in Boise, using its newfound leverage to stifle competition.


Dr. David C. Pate, chief executive of St. Luke’s, denied the assertions by St. Alphonsus that the hospital’s acquisitions had limited patient choice or always resulted in higher prices. In some cases, Dr. Pate said, services that had been underpriced were raised to reflect market value. St. Luke’s, he argued, is simply embracing the new model of health care, which he predicted would lead over the long term to lower overall costs as fewer unnecessary tests and procedures were performed.


Regulators expressed some skepticism about the results, for patients, of rapid consolidation, although the trend is still too new to know for sure. “We’re seeing a lot more consolidation than we did 10 years ago,” said Jeffrey Perry, an assistant director in the F.T.C.’s Bureau of Competition. “Historically, what we’ve seen with the consolidation in the health care industry is that prices go up, but quality does not improve.”


A Drive to Consolidate


An array of new economic realities, from reduced Medicare reimbursements to higher technology costs, is driving consolidation in health care and transforming the practice of medicine in Boise and other communities large and small. In one manifestation of the trend, hospitals, private equity firms and even health insurance companies are acquiring physician practices at a rapid rate.


Today, about 39 percent of doctors nationwide are independent, down from 57 percent in 2000, according to estimates by Accenture, a consulting firm.


Many policy experts praise the shift away from independent practices as a way of making health care less fragmented and expensive. Systems that employ doctors, modeled after well-known organizations like Kaiser Permanente, are better able to coordinate patient care and to find ways to deliver improved services at lower costs, these advocates say. Indeed, consolidation is encouraged by some aspects of the Obama administration’s health care law.


“If you’re going to be paid for value, for performance, you’ve got to perform together,” said Dr. Ricardo Martinez, chief medical officer for North Highland, an Atlanta-based consultant that works with hospitals.


The recent trend is reminiscent of the consolidation that swept the industry in the 1990s in response to the creation of health maintenance organizations, or H.M.O.’s — but there is one major difference. Then, hospitals had difficulty managing the practices, contending that doctors did not work as hard when they were employees as they had as private operators. Now, hospitals are writing contracts more in their own favor.


Read More..

Shortcuts: Why It’s Not All Bad to Be Bored


I SPENT five unexpected hours in an airport this Thanksgiving holiday when our plane had mechanical difficulties and we had to wait for another plane to arrive. So I had plenty of time to think about the subject of boredom.


I won’t lie to you. Half a day in an airport waiting for a flight is pretty tedious, even with the distractions of books, magazines and iPhones (not to mention duty-free shopping).


But increasingly, some academics and child development experts are coming out in praise of boredom.


It’s all right for us — and our children — to be bored on occasion, they say. It forces the brain to go on interesting tangents, perhaps fostering creativity. And because most of us are almost consistently plugged into one screen or another these days, we don’t experience the benefits of boredom.


So should we embrace boredom?


Yes. And no. But I’ll get back to that.


First of all, like many people, I assumed that boredom was a relatively recent phenomenon, with the advent of more leisure time. Not so, says Peter Toohey, a professor of Greek and Roman history at the University of Calgary in Canada and the author of “Boredom: A Lively History” (Yale University Press, 2011).


“Boredom actually has a very long history,” he said. “There’s Latin graffiti about boredom on the walls of Pompeii dating from the first century.”


Then there’s the question of how we define boredom. The trouble is that it has been defined, and discussed, in many different ways, said John D. Eastwood, an associate professor of psychology at York University in Ontario, Canada.


After looking over the research literature and putting the idea in front of a focus group of about 100 people, Professor Eastwood and his colleagues defined boredom as an experience of “wanting to, but being unable to engage in satisfying activity.”


What separates boredom from apathy, he said, is that the person is not engaged but wants to be. With apathy, he said, there is no urge to do something.


The core experience of boredom, he said, is “disruption of the attention process, associated with a low mood and a sense that time is passing slowly.”


Boredom can sound an awful lot like depression. But Professor Eastwood said that while they can be related, people who are bored tend to see the problem as the environment or the world, while people who are depressed see the problem as themselves.


Sometimes we think we’re bored when we just have difficulty concentrating. In their study, “The Unengaged Mind: Defining Boredom in Terms of Attention,” which appeared in the journal Perspectives on Psychological Science in September, Professor Eastwood and his colleagues pointed to an earlier experiment in which participants listened to a tape of a person reading a magazine article.


Some groups heard a loud and unrelated television program in the next room, others heard it at a low level so it was barely noticeable, while the third group didn’t hear the soundtrack at all.


The ones who heard the low-level TV reported more boredom than the other two groups — they had difficulty concentrating but were not sure why, and attributed that difficulty to boredom.


When you’re trying to focus on a difficult or engaging task, disruption of attention can lead to boredom, said Mark J. Fenske, an associate professor of neuroscience at the University of Guelph in Ontario and one of the authors of the study.


On the other hand, when you’re doing something dull, “such as looking for bad widgets on a factory line, distracting music can help you not be bored.”


In fact, he said, we now know that squirming and doodling, often seen as a sign of boredom, can actually help combat it by keeping people more physically alert.


“Research shows that kids who are allowed to fidget learn more and retain more information than those who are forced to sit still,” Professor Fenske said.


We all experience boredom at some points — my flight delay, a droning speaker, a particularly tedious movie. But some individuals are more likely to be bored than others. To help measure this, researchers developed a “Boredom Proneness Scale” in the 1980s.


The scale includes questions like, “Many things I have to do are repetitive and monotonous,” and “I have so many interests, I don’t have time to do everything.”


E-mail: shortcuts@nytimes.com



Read More..

General Assembly Grants Palestine Upgraded Status in U.N.


Damon Winter/The New York Times


The Palestinian Authority president, Mahmoud Abbas, center, was congratulated by Turkey’s foreign minister, Ahmet Davutoglu. More Photos »







UNITED NATIONS — More than 130 countries voted on Thursday to upgrade Palestine to a nonmember observer state of the United Nations, a triumph for Palestinian diplomacy and a sharp rebuke to the United States and Israel.




But the vote, at least for now, did little to bring either the Palestinians or the Israelis closer to the goal they claim to seek: two states living side by side, or increased Palestinian unity. Israel and the militant group Hamas both responded critically to the day’s events, though for different reasons.


The new status will give the Palestinians more tools to challenge Israel in international legal forums for its occupation activities in the West Bank, including settlement-building, and it helped bolster the Palestinian Authority, weakened after eight days of battle between its rival Hamas and Israel.


But even as a small but determined crowd of 2,000 celebrated in central Ramallah in the West Bank, waving flags and dancing, there was an underlying sense of concerned resignation.


“I hope this is good,” said Munir Shafie, 36, an electrical engineer who was there. “But how are we going to benefit?”


Still, the General Assembly vote — 138 countries in favor, 9 opposed and 41 abstaining — showed impressive backing for the Palestinians at a difficult time. It was taken on the 65th anniversary of the vote to divide the former British mandate of Palestine into two states, one Jewish and one Arab, a vote Israel considers the international seal of approval for its birth.


The past two years of Arab uprisings have marginalized the Palestinian cause to some extent as nations that focused their political aspirations on the Palestinian struggle have turned inward. The vote on Thursday, coming so soon after the Gaza fighting, put the Palestinians again — if briefly, perhaps — at the center of international discussion.


“The question is, where do we go from here and what does it mean?” Salam Fayyad, the Palestinian prime minister, who was in New York for the vote, said in an interview. “The sooner the tough rhetoric of this can subside and the more this is viewed as a logical consequence of many years of failure to move the process forward, the better.” He said nothing would change without deep American involvement.


President Mahmoud Abbas of the Palestinian Authority, speaking to the assembly’s member nations, said, “The General Assembly is called upon today to issue a birth certificate of the reality of the state of Palestine,” and he condemned what he called Israeli racism and colonialism. His remarks seemed aimed in part at Israel and in part at Hamas. But both quickly attacked him for the parts they found offensive.


“The world watched a defamatory and venomous speech that was full of mendacious propaganda against the Israel Defense Forces and the citizens of Israel,” Prime Minister Benjamin Netanyahu of Israel responded. “Someone who wants peace does not talk in such a manner.”


While Hamas had officially backed the United Nations bid of Mr. Abbas, it quickly criticized his speech because the group does not recognize Israel.


“There are controversial issues in the points that Abbas raised, and Hamas has the right to preserve its position over them,” said Salah al-Bardaweel, a spokesman for Hamas in Gaza, on Thursday.


“We do not recognize Israel, nor the partition of Palestine, and Israel has no right in Palestine,” he added. “Getting our membership in the U.N. bodies is our natural right, but without giving up any inch of Palestine’s soil.”


Israel’s ambassador to the United Nations, Ron Prosor, spoke after Mr. Abbas and said he was concerned that the Palestinian Authority failed to recognize Israel for what it is.


“Three months ago, Israel’s prime minister stood in this very hall and extended his hand in peace to President Abbas,” Mr. Prosor said. “He reiterated that his goal was to create a solution of two states for two peoples, where a demilitarized Palestinian state will recognize Israel as a Jewish state.


“That’s right. Two states for two peoples. In fact, President Abbas, I did not hear you use the phrase ‘two states for two peoples’ this afternoon. In fact, I have never heard you say the phrase ‘two states for two peoples’ because the Palestinian leadership has never recognized that Israel is the nation-state of the Jewish people.”


The Israelis also say that the fact that Mr. Abbas is not welcome in Gaza, the Palestinian coastal enclave run by Hamas, from which he was ejected five years ago, shows that there is no viable Palestinian leadership living up to its obligations now.


Jennifer Steinhauer contributed reporting from Washington, Isabel Kershner from Jerusalem, and Khaled Abu Aker from Ramallah, West Bank.



Read More..

Apple overcomes last hurdle, iPhone 5 cleared for sale in China as Android continues to dominate












Read More..

Falcons pick off Brees 5 times, beat Saints 23-13

ATLANTA (AP) — The Atlanta Falcons couldn't do anything offensively.

Not to worry.

The defense left Drew Brees with egg on his face.

Brees threw five interceptions for the first time in his career and, rubbing salt in the wound, the Falcons also ended his NFL-record streak of touchdown passes. The result was a 23-13 victory Thursday night that pushed Atlanta to the brink of a division championship and might have finished off the Saints' fading playoff hopes.

The Falcons (11-1) built an early 17-0 lead, then struggled to move the ball. They finished with 283 yards, by far the lowest total allowed this season by a Saints defense that was on pace to give up the most yards in NFL history.

But William Moore had two interceptions, and Thomas DeCoud, Sean Weatherspoon and Jonathan Babineaux had one pick apiece. Another by Corey Peters didn't count because of a penalty.

"That's the first time that's ever happened to me, so that's extremely disappointing," Brees said. "I pride myself on being a good decision-maker and not someone who will be a detriment to the game."

The Falcons will clinch the NFC South with a month to go if Tampa Bay loses at Denver on Sunday. The Saints (5-7) need to win out to have any chance, and even that might not be enough to get the defending division champs back to the playoffs.

"It looks pretty bleak right now," interim coach Joe Vitt said.

Brees had thrown a touchdown pass in 54 consecutive games, breaking Johnny Unitas' long-standing record earlier this season. There was an apparent scoring pass to Darren Sproles late in the first half, but it was nullified by a penalty.

"I didn't realize that until we walked off the field," Falcons coach Mike Smith said. "That's an unbelievable streak. Drew Brees is an outstanding quarterback. The way the defense played tonight speaks volumes. The guys had gone out there and thrown touchdown after touchdown game after game after game."

After Sproles' TD was wiped off the board, Brees made another huge mistake with New Orleans inside the Atlanta 10, allowing the clock to run out in the first half without at least attempting a field goal.

Four days earlier, Brees had two passes picked off and returned for touchdowns in a loss to San Francisco.

This one was even worse. He finished 28 of 50 for 341 yards but had a rating of just 37.6, the third-lowest off his career.

"I feel we have one of the best secondaries in the NFL," Falcons cornerback Dunta Robinson said, "and I think we came out and showed that."

When the Saints arrived in Atlanta, their bus was pelted by eggs at the airport, epitomizing the long rivalry between the teams. New Orleans had dominated in recent years, winning four in a row and 11 of 13.

This time, Michael Turner scored on Atlanta's opening possession, Tony Gonzalez hauled in a touchdown pass from Matt Ryan, and Matt Bryant booted three field goals, including a 55-yarder.

The defense did the rest.

"We got the monkey off our back," DeCoud said.

After winning so many close games, the Falcons started this one as if they were intent on routing the only team to beat them this season. New Orleans knocked off Atlanta 31-27 at the Superdome on Nov. 11, the bright spot in a tumultuous year that was marred by a bounty scandal and a season-long suspension for coach Sean Payton.

Ryan completed a pass on the first play from scrimmage before turning it over to a running game that has struggled most of the season. Turner burst around right end for a 35-yard gain. Jacquizz Rodgers broke off two straight 14-yard gains. Finally, it was Turner going in standing from 3 yards out, giving Atlanta a quick 7-0 lead.

That was Turner's 58th touchdown in five seasons with the Falcons, breaking the team record he had shared with Terance Mathis.

Atlanta struck again in the opening minute of the second period. Julio Jones hauled in an 18-yard throw from Ryan, setting up a 17-yard touchdown pass to Gonzalez in the back of the end zone. He beat former teammate Curtis Lofton; maybe as a sign of respect, Gonzo just flipped the ball over the crossbar instead of his customary basketball dunk.

Brees' second interception, this one a sloppy pass behind running Chris Ivory that deflected into the arms of Weatherspoon, set up Bryant's 45-yard field goal for a 17-0 lead.

Then, suddenly, the game completely changed.

For the rest of the second quarter and most of the third, the Saints totally dominated. Mark Ingram scored on a 1-yard run, capping an 11-play, 80-yard drive, and New Orleans should have tacked on more points at the end of the half. Brees made a rookie-like mistake with 12 seconds remaining, dumping a pass over the middle to Sproles with no timeouts. He was wrapped up at the Atlanta 3 and the clock ran out before the Saints could spike the ball.

"Honestly, I thought we had more time than we did," Brees said. "The last time I remember, we had 17 seconds. ... But it was down to 7 when I looked up after the completion. That wasn't enough time to get the spike. That's on me."

But New Orleans got the ball to start the second half, and Brees went back to work. This time, he made a couple of nifty moves to avoid sacks, completing six passes on an 83-yard drive consuming 15 plays and more than 6 1/2 minutes. But the Falcons held again, forcing Garrett Hartley to boot a 21-yard field goal that cut it to 17-10.

Hartley connected again from much farther out on the Saints' next possession, a 52-yarder that brought New Orleans even closer.

The Falcons, meanwhile, failed to pick up a first down on five straight possessions, a stretch in which the Saints had a 289-30 lead in total yards and a staggering 18 first downs.

But the Atlanta defense kept coming through when it counted.

Late in the third, Brees rolled to his right and threw over the middle. Moore stepped in front of the receiver and returned it to the New Orleans 16. Ryan connected on first-down throws to Gonzalez and Roddy White to set up Bryant for a 29-yarder that extended the lead back to a touchdown.

NOTES: Brees had two previous games with four interceptions. ... This was Brees' lowest-rated game since joining the Saints in 2006. With San Diego, he turned in a 35.7 at Washington in 2005 and a 26.8 at Chicago in 2003. ... Turner ran 12 times for 83 yards. ... Lance Moore of the Saints hauled in 11 passes for 123 yards.

___

Follow Paul Newberry on Twitter at www.twitter.com/pnewberry1963

Read More..

Recipes for Health: Asian Chopped Salad With Seasoned Tofu ‘Fingers’ — Recipes for Health


Andrew Scrivani for The New York Times







I like to serve the baked seasoned tofu “fingers” warm on top of the salad. They are delicious cold, too; it is worth making up a separate batch for the refrigerator. If you have an assortment of vegetables leftover from Thanksgiving dinner, throw them in!




For the Tofu:


1/4 cup soy sauce


2 tablespoons mirin (sweet Japanese rice wine)


1 tablespoon rice vinegar


1 tablespoon minced or grated fresh ginger


1/2 teaspoon sugar


1 tablespoon Asian sesame oil


1 pound firm tofu


For the salad:


1 romaine heart, chopped


5 cups mixed chopped or diced vegetables such as:


Green or red cabbage


Celery (from the inner heart)


Red pepper


Radishes, sliced or chopped


1/4 cup dry roasted peanuts, coarsely chopped


1/4 cup chopped cilantro (more to taste)


1 serrano pepper, seeded and minced (optional)


For the dressing:


2 tablespoons fresh lime juice


1/4 cup tofu marinade, above


2 tablespoons canola or peanut oil


1/3 cup low-fat buttermilk or plain nonfat yogurt


1. Marinate the tofu: combine the soy sauce, mirin, rice vinegar, ginger and sugar in a 2-quart bowl. Whisk in the sesame oil and combine well. Drain the tofu and pat dry with paper towels. Slice into 1/3-inch thick slabs and cut the slabs in half lengthwise to get “fingers” approximately 1/3 inch thick by 3/4 inch wide. Blot each finger with paper towels. Add to the bowl with the marinade and gently toss to coat. Cover and refrigerate for 15 minutes to an hour, or for up to a day.


2. Meanwhile, heat the oven to 375 degrees and line a baking sheet with parchment. Lift the tofu out of the marinade and arrange the pieces on the parchment-covered baking sheet. Bake for 7 to 10 minutes, until the edges are just beginning to color and the marinade sets on the surface of the tofu. Remove from the heat.


3. In a large bowl, combine all of the salad ingredients. Whisk together the dressing ingredients and toss with the salad. If desired, transfer to a platter. Garnish with the tofu strips and serve.


Yield: Serves 4


Advance preparation: The chopped vegetables can be prepared up to a day ahead and refrigerated in a well covered container. The tofu marinade will keep for two days in the refrigerator. The baked seasoned tofu will keep for several days in the refrigerator.


Nutritional information per serving: 317 calories; 20 grams fat; 2 grams saturated fat; 8 grams polyunsaturated fat; 9 grams monounsaturated fat; 1 milligram cholesterol; 19 grams carbohydrates; 5 grams dietary fiber; 470 milligrams sodium (does not include salt to taste); 16 grams protein


Martha Rose Shulman is the author of “The Very Best of Recipes for Health.”


Read More..

U.S. Is Weighing Stronger Action in Syrian Conflict


Francisco Leong/Agence France-Presse — Getty Images


Rebels in northern Syria celebrated on Wednesday next to what was reported to be a government fighter jet.







WASHINGTON — The Obama administration, hoping that the conflict in Syria has reached a turning point, is considering deeper intervention to help push President Bashar al-Assad from power, according to government officials involved in the discussions.




While no decisions have been made, the administration is considering several alternatives, including directly providing arms to some opposition fighters.


The most urgent decision, likely to come next week, is whether NATO should deploy surface-to-air missiles in Turkey, ostensibly to protect that country from Syrian missiles that could carry chemical weapons. The State Department spokeswoman, Victoria Nuland, said Wednesday that the Patriot missile system would not be “for use beyond the Turkish border.”


But some strategists and administration officials believe that Syrian Air Force pilots might fear how else the missile batteries could be used. If so, they could be intimidated from bombing the northern Syrian border towns where the rebels control considerable territory. A NATO survey team is in Turkey, examining possible sites for the batteries.


Other, more distant options include directly providing arms to opposition fighters rather than only continuing to use other countries, especially Qatar, to do so. A riskier course would be to insert C.I.A. officers or allied intelligence services on the ground in Syria, to work more closely with opposition fighters in areas that they now largely control.


Administration officials discussed all of these steps before the presidential election. But the combination of President Obama’s re-election, which has made the White House more willing to take risks, and a series of recent tactical successes by rebel forces, one senior administration official said, “has given this debate a new urgency, and a new focus.”


The outcome of the broader debate about how heavily America should intervene in another Middle Eastern conflict remains uncertain. Mr. Obama’s record in intervening in the Arab Spring has been cautious: While he joined in what began as a humanitarian effort in Libya, he refused to put American military forces on the ground and, with the exception of a C.I.A. and diplomatic presence, ended the American role as soon as Col. Muammar el-Qaddafi was toppled.


In the case of Syria, a far more complex conflict than Libya’s, some officials continue to worry that the risks of intervention — both in American lives and in setting off a broader conflict, potentially involving Turkey — are too great to justify action. Others argue that more aggressive steps are justified in Syria by the loss in life there, the risks that its chemical weapons could get loose, and the opportunity to deal a blow to Iran’s only ally in the region. The debate now coursing through the White House, the Pentagon, the State Department and the C.I.A. resembles a similar one among America’s main allies.


“Look, let’s be frank, what we’ve done over the last 18 months hasn’t been enough,” Britain’s prime minister, David Cameron, said three weeks ago after visiting a Syrian refugee camp in Jordan. “The slaughter continues, the bloodshed is appalling, the bad effects it’s having on the region, the radicalization, but also the humanitarian crisis that is engulfing Syria. So let’s work together on really pushing what more we can do.” Mr. Cameron has discussed those options directly with Mr. Obama, White House officials say.


France and Britain have recognized a newly formed coalition of opposition groups, which the United States helped piece together. So far, Washington has not done so.


American officials and independent specialists on Syria said that the administration was reviewing its Syria policy in part to gain credibility and sway with opposition fighters, who have seized key Syrian military bases in recent weeks.


“The administration has figured out that if they don’t start doing something, the war will be over and they won’t have any influence over the combat forces on the ground,” said Jeffrey White, a former Defense Intelligence Agency intelligence officer and specialist on the Syria military. “They may have some influence with various political groups and factions, but they won’t have influence with the fighters, and the fighters will control the territory.”


Jessica Brandt contributed reporting from Cambridge, Mass.



Read More..

Bonds, Clemens, Sosa on Hall ballot for first time

NEW YORK (AP) — The most polarizing Hall of Fame debate since Pete Rose will now be decided by the baseball shrine's voters: Do Barry Bonds, Roger Clemens and Sammy Sosa belong in Cooperstown despite drug allegations that tainted their huge numbers?

In a monthlong election sure to become a referendum on the Steroids Era, the Hall ballot was released Wednesday, and Bonds, Clemens and Sosa are on it for the first time.

Bonds is the all-time home run champion with 762 and won a record seven MVP awards. Clemens took home a record seven Cy Young trophies and is ninth with 354 victories. Sosa ranks eighth on the homer chart with 609.

Yet for all their HRs, RBIs and Ws, the shadow of PEDs looms large.

"You could see for years that this particular ballot was going to be controversial and divisive to an unprecedented extent," Larry Stone of The Seattle Times wrote in an email. "My hope is that some clarity begins to emerge over the Hall of Fame status of those linked to performance-enhancing drugs. But I doubt it."

More than 600 longtime members of the Baseball Writers' Association of America will vote on the 37-player ballot. Candidates require 75 percent for induction, and the results will be announced Jan. 9.

Craig Biggio, Mike Piazza and Curt Schilling also are among the 24 first-time eligibles. Jack Morris, Jeff Bagwell and Tim Raines are the top holdover candidates.

If recent history is any indication, the odds are solidly stacked against Bonds, Clemens and Sosa. Mark McGwire and Rafael Palmeiro both posted Cooperstown-caliber stats, too, but drug clouds doomed them in Hall voting.

Some who favor Bonds and Clemens claim the bulk of their accomplishments came before baseball got wrapped up in drug scandals. They add that PED use was so prevalent in the 1980s, 1990s and early 2000s that it's unfair to exclude anyone because so many who-did-and-who-didn't questions remain.

Many fans on the other side say drug cheats — suspected or otherwise — should never be afforded the game's highest individual honor.

Either way, this election is baseball's newest hot button, generating the most fervent Hall arguments since Rose. The discussion about Rose was moot, however — the game's career hits leader agreed to a lifetime ban in 1989 after an investigation concluded he bet on games while managing the Cincinnati Reds, and that barred him from the BBWAA ballot.

The BBWAA election rules allow voters to pick up to 10 candidates. As for criteria, this is the only instruction: "Voting shall be based upon the player's record, playing ability, integrity, sportsmanship, character, and contributions to the team(s) on which the player played."

That leaves a lot of room for interpretation.

Bonds, Clemens and Sosa won't get a vote from Mike Klis of The Denver Post.

"Nay on all three. I think in all three cases, their performances were artificially enhanced. Especially in the cases of Bonds and Clemens, their production went up abnormally late in their careers," he wrote in an email.

They'll do better with Bob Dutton of The Kansas City Star.

"I plan to vote for all three. I understand the steroid/PED questions surrounding each one, and I've wrestled with the implications," he wrote in an email.

"My view is these guys played and posted Hall of Fame-type numbers against the competition of their time. That will be my sole yardstick. If Major League Baseball took no action against a player during his career for alleged or suspected steroid/PED use, I'm not going to do so in assessing their career for the Hall of Fame," he said.

San Jose Mercury News columnist Mark Purdy will reserve judgment.

"At the beginning of all this, I made up my mind I had to adopt a consistent policy on the steroid social club. So, my policy has been, with the brilliance in the way they set up the Hall of Fame vote where these guys have a 15-year window, I'm not going to vote for any of those guys until I get the best picture possible of what was happening then," he wrote in an email.

"We learn a little bit more each year. We learned a lot during the Bonds trial. We learned a lot during the Clemens trial. I don't want to say I'm never going to vote for any of them. I want to wait until the end of their eligibility window and have my best idea of what was really going on," he said.

Clemens was acquitted this summer in federal court on six counts that he lied and obstructed Congress when he denied using performance-enhancing drugs.

Bonds was found guilty in 2011 by a federal court jury on one count of obstruction of justice, ruling he gave an evasive answer in 2003 to a grand jury looking into the distribution of illegal steroids. Bonds is appealing the verdict.

McGwire is 10th on the career home run list with 583, but has never received even 24 percent in his six Hall tries. Big Mac has admitted to using steroids and human growth hormone.

Palmeiro is among only four players with 500 homers and 3,000 hits, yet has gotten a high of just 12.6 percent in his two years on the ballot. He drew a 10-day suspension in 2005 after a positive test for PEDs, and said the result was due to a vitamin vial given to him by teammate Miguel Tejada.

Biggio topped the 3,000-hit mark — which always has been considered an automatic credential for Cooperstown — and spent his entire career with the Houston Astros.

"Hopefully, the writers feel strongly that they liked what they saw, and we'll see what happens," Biggio said last week.

Schilling was 216-146 and won three World Series championships, including his "bloody sock" performance for the Boston Red Sox in 2004.

___

AP Baseball Writer Janie McCauley and AP Sports Writers Arnie Stapleton and Dave Skretta contributed to this report.

Read More..

Cost of Brand-Name Prescription Medicines Soaring





The price of brand-name prescription medicines is rising far faster than the inflation rate, while the price of generic drugs has plummeted, creating the largest gap so far between the two, according to a report published Wednesday by the pharmacy benefits manager Express Scripts.




The report tracked an index of commonly used drugs and found that the price of brand-name medicines increased more than 13 percent from September 2011 to this September, which it said was more than six times the overall price inflation of consumer goods. Generic drug prices dipped by nearly 22 percent.


The drop in the price of generics “represents low-hanging fruit for the country to save money on health care,” said Dr. Steve Miller, the chief medical officer of Express Scripts, which manages the drug benefits for employers and insurers and also runs a mail-order pharmacy.


The report was based on a random sample of six million Express Scripts members with prescription drug coverage.


The Pharmaceutical Research and Manufacturers of America, the trade group representing brand-name manufacturers, criticized the report, saying it was skewed by a handful of high-priced specialty drugs that are used by a small number of patients and overlooked the crucial role of major drug makers.


“Without the development of new medicines by innovator companies, there would be neither the new treatments essential to progress against diseases nor generic copies,” Josephine Martin, executive vice president of the group, said in a statement.


The report cited the growth of specialty drugs, which treat diseases like cancer and multiple sclerosis, as a major reason for the increase in spending on branded drugs. Spending on specialty medicines increased nearly 23 percent during the first three quarters of 2012, compared with the same period in 2011. All but one of the new medicines approved in the third quarter of this year were specialty drugs, the report found, and many of them were approved to treat advanced cancers only when other drugs had failed.


Stephen W. Schondelmeyer, a professor of pharmaceutical economics at the University of Minnesota, said the potential benefits of many new drugs did not always match the lofty price tags. “Increasingly it’s going to be difficult for drug-benefit programs to make decisions about coverage and payment and which drugs to include,” said Mr. Schondelmeyer, who conducts a similar price report for AARP. He also helps manage the drug benefit program for the University of Minnesota.


“We’re going to be faced with the issue that any drug at any price will not be sustainable.”


Spending on traditional medicines — which treat common ailments like high cholesterol and blood pressure — actually declined by 0.6 percent during the period, the report found. That decline was mainly because of the patent expiration of several blockbuster drugs, like Lipitor and Plavix, which opened the market for generic competitors. But even as the entry of generic alternatives pushed down spending, drug companies continued to raise prices on their branded products, in part to squeeze as much revenue as possible out of an ever-shrinking portfolio, Dr. Miller said.


Drug makers are also being pushed by from companies like Express Scripts and health insurers, which are increasingly looking for ways to cut costs, said C. Anthony Butler, a pharmaceuticals analyst at Barclays. “I think they’re pricing where they can but what they keep telling me is they’re under significant pressure” to keep prices low, he said.


Express Scripts earns higher profits from greater use of generic medicines than brand name drugs sold through their mail-order pharmacy, Mr. Butler said. “There’s no question that they would love for everybody to be on a generic,” he said.


Dr. Miller acknowledged that was true but said that ultimately, everyone wins. “When we save people money, that’s when we make money,” he said. “We don’t shy away from that.”


Read More..